Scott B. Han

Netarsudil/Latanoprost Fixed-Dose Combination for Elevated Intraocular Pressure: Three-Month Data from a Randomized Phase 3 Trial

Sanjay Asrani, Alan Lee Robin, Janet B. Serle, Richard Alan Lewis et autres

PURPOSE: To compare the ocular hypotensive efficacy and safety of a fixed-dose combination (FDC) of the Rho kinase inhibitor netarsudil and latanoprost vs monotherapy with netarsudil or latanoprost. DESIGN: Three-month primary endpoint analysis of a randomized, double-masked, phase 3 clinical trial. METHODS: …

us (code pays fourni par la source)

Understanding Sjögren’s syndrome

Scott B. Han, Od, Faao

Sjogren syndrome is a systemic multi-organ autoimmune disease that results in chronic inflammation. Progressive B-cell and T-cell infiltration of the exocrine organs primarily targets the lacrimal and salivary glands. This results in the classic presentation of dry eye and dry mouth symptoms. …

Raise the bar for diagnosing, treating acute conjunctivitis

Scott B. Han, Od, Faao

A dedicated red eye protocol for conjunctivitis can enable a practice to achieve early and accurate diagnosis of acute conjunctivitis.